This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, F. Y. F. Articles by Keng, P. C. Search for Related Content PubMed PubMed Citation Articles by Lee, F. Y. F. Articles by Keng, P. C.

Glutathione Contents in Human and Rodent Tumor Cells in Various Phases of the Cell Cycle¹

Experimental Therapeutics Division and Department of Radiation Oncology, University of Rochester Cancer Center, Rochester, New York 14642

Experiments were carried out to investigate whether or not the cell cycle dependent cytotoxicity of adriamycin (ADR) was a consequence of variations in cellular glutathione (GSH) levels in different phases of the cell cycle. The GSH content of a range of rodent and human tumor cell lines, grown both in vivo and in vitro, were measured by high performance liquid chromatography. Enrichment of cells in various cell cycle phases was accomplished by centrifugal elutriation. The GSH content of cells in the different phases of the cell cycle increased in proportion to the increases in cell volume from G₁ to S phase to G₂-M. However, the apparent differences in GSH content across the cell cycle were eliminated when GSH content was normalized according to cell volume. This observation held true for all cell lines studied. The cell cycle dependent cytotoxicity of ADR therefore was not related to cell cycle dependent variations in GSH content. Buthionine sulfoximine, a specific inhibitor of GSH synthesis, depleted the GSH of cells in G₁, S, and G₂-M of the cell cycle by similar rates and enhanced the cytotoxicity of ADR to similar extents. These results suggest that although GSH does confer a significant degree of protection against the toxic effects of ADR in general, the more specific differences in response to ADR across the cell cycle probably were not the consequence of thiol variations but rather the result of other as yet unidentified factors.

¹ This work was supported by NIH grants CA-36858 and CA-11051. The support of the Cell Separation and Flow Cytometry Facilities and the Animal Tumor Research/Xenograft Facility of the University of Rochester Cancer Center is gratefully acknowledged.

² To whom requests for reprints should be addressed, at University of Rochester Cancer Center, 601 Elmwood Avenue, Box 704, Rochester, NY 14642.

³ Present address: Department of Radiobiology, Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T6G 1Z2.

Received 9/21/87. Revised 1/29/88. Accepted 4/ 6/88.

This article has been cited by other articles:

				S. C. LU Regulation of hepatic glutathione synthesis: current concepts and controversies FASEB J, July 1, 1999; 13(10): 1169 - 1183. [Abstract] [Full Text]